Vaccination Uptake in Chronic Disease Patients: Examining Attitudes and Anxiety Levels - Scorecard - MDSpire

Vaccination Uptake in Chronic Disease Patients: Examining Attitudes and Anxiety Levels

  • By

  • Anna Lewandowska

  • Tomasz Lewandowski

  • Grzegorz Rudzki

  • Michał Próchnicki

  • Anna Bartosiewicz

  • Aleksandra Stryjkowska-Góra

  • Tomasz Góra

  • Barbara Zych

  • Barbara Laskowska

  • Agnieszka Bielec

  • Beata Bida

  • December 24, 2025

  • 0 min

Share

Clinical Scorecard: Vaccination Uptake in Chronic Disease Patients: Examining Attitudes and Anxiety Levels

At a Glance

CategoryDetail
ConditionChronic diseases and immunocompromised states
Key MechanismsImpaired immunity leading to increased risk of severe infectious diseases
Target PopulationPatients with chronic illnesses, including oncology patients and those with COPD
Care SettingClinical settings, particularly hospitals

Key Highlights

  • Vaccination is crucial for high-risk groups to prevent severe disease progression.
  • Oncology patients face a significantly higher risk of severe complications from infections.
  • Vaccination rates among chronically ill patients remain unsatisfactory despite guidelines.
  • Anxiety related to illness may influence attitudes toward vaccination.
  • Specific vaccines recommended include influenza, pneumococcal, and COVID-19 vaccines.

Guideline-Based Recommendations

Diagnosis

  • Assess chronic conditions and immunocompromised status.

Management

  • Implement specialized vaccination protocols for chronic disease patients.

Monitoring & Follow-up

  • Evaluate vaccination uptake and patient attitudes regularly.

Risks

  • Patients with chronic diseases have a higher risk of severe infectious disease complications.

Patient & Prescribing Data

Patients with chronic diseases such as cancer, COPD, and other immunocompromising conditions.

Vaccination is essential for preventing infections in this vulnerable population.

Clinical Best Practices

  • Follow ECDC guidelines for vaccination in chronic disease patients.
  • Encourage vaccination among oncology patients and those undergoing immunosuppressive therapy.
  • Address barriers to vaccination through patient education and support.

References

Original Source(s)

Related Content